Zydus Pharmaceuticals (USA) Inc.

États‑Unis d’Amérique



Quantité totale PI	9
Quantité totale incluant filiales	37 (+ 28 pour les filiales)
Rang # Quantité totale PI	171 382
Note d'activité PI	1,3/5.0 4
Rang # Activité PI	238 499
Parent	Cadila Healthcare Limited
Classe Nice dominante	Produits pharmaceutiques, vétéri...

	Brevets	Marques
	0	9
	0	0
	0	0
		0

Dernière marque

2025 - LIQENZA

Première marque

2004 - ZYGENERICS

Filiales

3 subsidiaries with IP (25 patents, 3 trademarks)

1 subsidiaries without IP

S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025	P/S	Medicinal preparations for the treatment of prostate cancer; Pharmaceutical preparations for the ...
2022	P/S	Pharmaceutical preparations for treating diabetes
	P/S	Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharm...
	P/S	Pharmaceutical preparations for the treatment of diabetes only, not for intravenous administratio...
2020	P/S	Downloadable mobile software and mobile applications for mobile phones, portable media players, a...
2018	P/S	auto-injection devices for medical use
2016	P/S	Pharmaceutical preparations for the treatment of hypertension, high blood pressure, angina, chest...
2004	P/S	House mark for a full line of pharmaceutical preparations